Over the last 7 days, the Biotech industry has dropped 6.1%, driven by Idorsia declining 15%. The industry has fallen 42% in the last year. As for the next few years, earnings are expected to grow by 7.5% per annum.
Has the Swiss Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 27 Sep 2023 | CHF263.1m | CHF318.9m | -CHF219,592,353.00 | n/a | -1.2x | 0.8x |
Fri, 25 Aug 2023 | CHF298.5m | CHF330.3m | -CHF177,182,325.00 | n/a | -1.7x | 0.9x |
Sun, 23 Jul 2023 | CHF326.7m | CHF321.5m | -CHF179,828,989.00 | n/a | -1.8x | 1x |
Tue, 20 Jun 2023 | CHF314.1m | CHF330.4m | -CHF180,808,144.00 | n/a | -1.7x | 1x |
Thu, 18 May 2023 | CHF352.4m | CHF330.2m | -CHF183,173,955.00 | n/a | -1.9x | 1.1x |
Sat, 15 Apr 2023 | CHF425.3m | CHF491.2m | CHF8.2m | 1.6x | 51.9x | 0.9x |
Mon, 13 Mar 2023 | CHF464.5m | CHF494.3m | CHF15.0m | 1.6x | 31x | 0.9x |
Wed, 08 Feb 2023 | CHF503.5m | CHF493.4m | CHF14.5m | 1.7x | 34.7x | 1x |
Fri, 06 Jan 2023 | CHF500.3m | CHF493.4m | CHF14.5m | 1.7x | 34.5x | 1x |
Sun, 04 Dec 2022 | CHF525.8m | CHF493.4m | CHF14.5m | 1.9x | 36.3x | 1.1x |
Tue, 01 Nov 2022 | CHF510.1m | CHF510.1m | CHF14.8m | 1.8x | 34.4x | 1x |
Thu, 29 Sep 2022 | CHF516.5m | CHF504.9m | CHF15.9m | 1.9x | 32.4x | 1x |
Sat, 27 Aug 2022 | CHF500.6m | CHF488.0m | CHF36.1m | 1.8x | 13.9x | 1x |
Mon, 25 Jul 2022 | CHF529.5m | CHF486.8m | CHF42.3m | 1.8x | 12.5x | 1.1x |
Wed, 22 Jun 2022 | CHF523.6m | CHF456.6m | CHF81.1m | 2.1x | 6.5x | 1.1x |
Fri, 20 May 2022 | CHF720.1m | CHF470.3m | CHF25.0m | 2x | 28.8x | 1.5x |
Sun, 17 Apr 2022 | CHF1.1b | CHF291.5m | -CHF142,580,258.00 | 1.9x | -7.7x | 3.8x |
Tue, 15 Mar 2022 | CHF1.3b | CHF284.2m | -CHF140,782,084.00 | 1.9x | -9x | 4.5x |
Thu, 10 Feb 2022 | CHF4.6b | CHF318.4m | -CHF658,875,581.00 | 1.8x | -7x | 14.4x |
Sat, 08 Jan 2022 | CHF4.7b | CHF317.7m | -CHF658,979,620.00 | 1.5x | -7.1x | 14.7x |
Mon, 06 Dec 2021 | CHF3.8b | CHF317.4m | -CHF659,021,385.00 | 1.5x | -5.7x | 11.8x |
Wed, 03 Nov 2021 | CHF4.3b | CHF315.5m | -CHF658,911,116.00 | 2.3x | -6.5x | 13.6x |
Fri, 01 Oct 2021 | CHF5.3b | CHF288.9m | -CHF590,639,030.00 | 4.9x | -8.9x | 18.2x |
Sun, 29 Aug 2021 | CHF5.1b | CHF306.0m | -CHF612,309,374.80 | 1.1x | -8.4x | 16.8x |
Mon, 05 Jul 2021 | CHF5.8b | CHF306.0m | -CHF612,309,374.80 | 1.1x | -9.4x | 18.8x |
Thu, 08 Apr 2021 | CHF6.2b | CHF352.3m | -CHF535,605,963.80 | 3.8x | -11.6x | 17.7x |
Sun, 10 Jan 2021 | CHF6.1b | CHF407.2m | -CHF561,055,198.50 | 7.1x | -10.9x | 15x |
Sat, 03 Oct 2020 | CHF5.7b | CHF399.6m | -CHF565,530,866.50 | 1x | -10.1x | 14.3x |
-10.1x
How does Swiss Biotech compare with similar industries?
CH Market | -1.29% | |
Healthcare | -1.08% | |
Biotech | -3.03% | |
Biotech | -3.03% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MOLN Molecular Partners | CHF3.91 | 0.8% +CHF985.1k | -37.4% | PS15x |